Abstract
Percutaneous pulmonary valve implantation (PPVI) has revolutionized the management of right ventricular outflow tract dysfunction after repaired congenital heart disease. The technology is considered to be safe, with a relatively low complication rate. Infection is one of the described complications of PPVI, and to date five cases of culture-positive infective endocarditis of percutaneously implanted pulmonary valve have been reported worldwide. Herein is reported the first ever case of culture-negative endocarditis of a percutaneously implanted pulmonary valve, caused by Bartonella henselae, five years after implantation in a 15-year-old patient with a repaired truncus arteriosus.
MeSH terms
-
Adolescent
-
Anti-Bacterial Agents / therapeutic use
-
Bartonella henselae / isolation & purification*
-
Bioprosthesis*
-
Cardiac Surgical Procedures / adverse effects*
-
Device Removal
-
Echocardiography, Doppler, Color
-
Echocardiography, Three-Dimensional
-
Endocarditis, Bacterial / diagnostic imaging
-
Endocarditis, Bacterial / microbiology*
-
Endocarditis, Bacterial / therapy
-
Heart Valve Prosthesis Implantation / instrumentation*
-
Heart Valve Prosthesis*
-
Humans
-
Male
-
Prosthesis-Related Infections / diagnostic imaging
-
Prosthesis-Related Infections / microbiology*
-
Prosthesis-Related Infections / therapy
-
Pulmonary Valve / transplantation*
-
Pulmonary Valve Insufficiency / etiology
-
Pulmonary Valve Insufficiency / surgery*
-
Reoperation
-
Transplantation, Homologous
-
Treatment Outcome
-
Truncus Arteriosus / surgery
-
Ventricular Outflow Obstruction / etiology
-
Ventricular Outflow Obstruction / surgery*